Aurélie Dutour

1.2k total citations
35 papers, 829 citations indexed

About

Aurélie Dutour is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Aurélie Dutour has authored 35 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Aurélie Dutour's work include Sarcoma Diagnosis and Treatment (14 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Aurélie Dutour is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Aurélie Dutour collaborates with scholars based in France, United States and Italy. Aurélie Dutour's co-authors include Jean‐Yves Blay, Malcolm K. Brenner, Daniel Pissaloux, Eric Yvon, Jennifer Perez, Michel Rigaud, Laurent Alberti, Michele Del Vecchio, Barbara Savoldo and Valentina Hoyos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Aurélie Dutour

33 papers receiving 820 citations

Peers

Countries citing papers authored by Aurélie Dutour

Since Specialization

Citations

This map shows the geographic impact of Aurélie Dutour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Dutour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Dutour more than expected).

Fields of papers citing papers by Aurélie Dutour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Dutour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Dutour. The network helps show where Aurélie Dutour may publish in the future.

Co-authorship network of co-authors of Aurélie Dutour

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Dutour. A scholar is included among the top collaborators of Aurélie Dutour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Dutour. Aurélie Dutour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers 2025 ·ESMO Open ·Jean‐Yves Blay, (unknown), Armelle Dufresne, (unknown), Virginie Avrillon, Souad Assaad, C. Decroisette, Bénédicte Mastroïanni, (unknown), (unknown), (unknown), Pierre Méeus, Aurélie Dutour, Marie Castets, M. Pérol, Pierre-Étienne Heudel	0
2	The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma 2023 ·Life Science Alliance ·(unknown), Virginie Millet, A. Roger, Romain Fenouil, Catherine Tardivel, Jean‐Charles Martin, (unknown), Laetitia Shintu, (unknown), (unknown), Bernard Malissen, Sandrine Henri, Sophie Ugolini, Aurélie Dutour, Pascal Finetti, François Bertucci, Jean‐Yves Blay, Franck Galland, Philippe Naquet	6
3	A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages 2023 ·Cancers ·(unknown), (unknown), (unknown), А. В. Новиков, Kamel Chettab, (unknown), Charles Dumontet, Marie Karanian, Jérôme Kerzerho, Martine Caroff, Jean‐Yves Blay, Aurélie Dutour	11
4	1969P Intratumoral immune infiltrates in chondrosarcoma (ChS) 2023 ·Annals of Oncology ·Piotr Rutkowski, Anna Szumera‐Ciećkiewicz, Agnieszka Zając, (unknown), Michał Wągrodzki, Pawel Michalak, Paweł Teterycz, Emanuela Palmerini, Marco Gambarotti, Giorgio Frega, Michela Pierini, Alberto Righi, Giovanna Magagnoli, Aurélie Dutour, Myriam Jean‐Denis, Toni Ibrahim, Jean‐Yves Blay, Anna M. Czarnecka	2
5	An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity 2023 ·Life Science Alliance ·(unknown), Virginie Millet, (unknown), A. Modelska, Lydie Crescence, Sandrine Roulland, Sandrine Henri, Bernard Malissen, Nicolas Brouilly, Laurence Panicot‐Dubois, Renaud Vincentelli, Gerlind Sulzenbacher, Pascal Finetti, Aurélie Dutour, Jean‐Yves Blay, François Bertucci, Franck Galland, Philippe Naquet	5
6	Toward cancer characterization using light backscattering spectroscopy and quantitative ultrasound 2023 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), Pauline Muleki-Seya, Aurélie Dutour, (unknown), Hervé Liebgott, Bruno Montcel	1
7	Radiotherapy in bone sarcoma: the quest for better treatment option 2023 ·BMC Cancer ·(unknown), Mehdi Brahmi, Jean‐Yves Blay, Aurélie Dutour	12
8	Cancer characterization using light backscattering spectroscopy and quantitative ultrasound: an ex vivo study on sarcoma subtypes 2023 ·Scientific Reports ·(unknown), Bruno Montcel, Aurélie Dutour, (unknown), Hervé Liebgott, Pauline Muleki-Seya	1
9	Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models 2021 ·Cells ·(unknown), (unknown), (unknown), (unknown), Daniel Pissaloux, Franck Tirode, (unknown), (unknown), (unknown), Marie Karanian, Raul Perret, Olivier Gille, Jean‐Yves Blay, Aurélie Dutour	4
10	Caspase-8 deficiency induces a switch from TLR3 induced apoptosis to lysosomal cell death in neuroblastoma 2021 ·Scientific Reports ·(unknown), Gabriel Ichim, (unknown), Aurélie Dutour, Serge Lebecque, Marie Castets, Kathrin Weber	6
11	Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23 2019 ·Cancer Discovery ·Maya Kansara, (unknown), Puiyi Pang, Aurélie Dutour, Lisa Mirabello, Francine Acher, Jean‐Philippe Pin, Elizabeth G. Demicco, Juming Yan, Michele W.L. Teng, Mark J. Smyth, David M. Thomas	35
12	Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma 2018 ·Oncogenesis ·Yvonne de Jong, (unknown), (unknown), (unknown), (unknown), Jolieke G. van Oosterwijk, Jean‐Yves Blay, Aurélie Dutour, Judith V.M.G. Bovée	41
13	Targeted imaging of αvβ3 expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: A potential tool to reduce incomplete surgical resection 2014 ·Bone ·Aurélie Dutour, Véronique Josserand, (unknown), (unknown), (unknown), Franck Chotel, (unknown), P. Rizo, Jean‐Luc Coll, Jean‐Yves Blay	13
14	Staphylococcal entertotoxins of the enterotoxin Gene cluster (egcSEs) induce nitrous oxide- and cytokine dependent tumor cell apoptosis in a broad panel of human tumor cells 2013 ·Frontiers in Cellular and Infection Microbiology ·David S. Terman, (unknown), Olivier Dauwalder, (unknown), Aurélie Dutour, Damien Thomas, Virginie Brun, Jacques Bienvenu, (unknown), François Vandenesch, Gérard Lina	16
15	Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model 2012 ·PLoS ONE ·Jennifer Perez, (unknown), (unknown), Daniel Pissaloux, (unknown), (unknown), Jean‐Yves Blay, Aurélie Dutour	48
16	Therapeutic pipeline for soft-tissue sarcoma 2011 ·Expert Opinion on Pharmacotherapy ·Philippe A. Cassier, Sana Intidhar Labidi‐Galy, Pierre-Étienne Heudel, Aurélie Dutour, Pierre Méeus, (unknown), Laurent Alberti, Isabelle Ray‐Coquard, Jean‐Yves Blay	6
17	Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells 2009 ·Clinical Cancer Research ·Eric Yvon, Michele Del Vecchio, Barbara Savoldo, Valentina Hoyos, Aurélie Dutour, Andrea Anichini, Gianpietro Dotti, Malcolm K. Brenner	113
18	¹⁸F-FDG PET SUVmax Correlates with Osteosarcoma Histologic Response to Neoadjuvant Chemotherapy: Preclinical Evaluation in an Orthotopic Rat Model 2009 ·Journal of Nuclear Medicine ·Aurélie Dutour, Anne‐Valérie Decouvelaere, Jacques Monteil, (unknown), (unknown), Raphaël F. Rousseau, Perrine Marec‐Bérard	10
19	Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype. 2008 ·PubMed ·Aurélie Dutour, (unknown), Jacques Monteil, François Paraf, J.-L. Charissoux, Raphaël F. Rousseau, Michel Rigaud	12
20	Endostatin cDNA/Cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor 2004 ·Molecular Therapy ·Aurélie Dutour, Jacques Monteil, François Paraf, (unknown), Cortina Kaletta, Birgitta Sauer, Kurt Naujoks, Michel Rigaud	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact